This study draws on data collected from a voluntary family register of APKD over 10 years. Records of 150 families were examined, ultrasound reports were obtained from 242 people at 50% prior risk, and 37 families were typed for DNA markers. The fraction of APKD resulting from loci unlinked to PKD1 (designated PKD2 here) was calculated at 2-94% (upper confidence limit 8-62%). Some subjects who were negative on initial scan later gave a positive scan, but there was no example of a definite gene carrier aged over 30 giving a negative scan. In families large enough for linkage analysis, most people who were at 50% prior risk could be given a final risk below 5% or above 95%, by using combined ultrasound and DNA studies.
J O'Donoghue, A P Read, S Rimmer, Abstract Diagnosis of autosomal dominant adult polycystic kidney disease (APKD) is possible by ultrasonographic scanning (USS) or by using DNA markers linked to the PKD1 locus. Ultrasonography is complicated by the age dependent penetrance of the gene and linkage studies are subject to recombination errors owing to meiotic crossing over and locus heterogeneity.
This study draws on data collected from a voluntary family register of APKD over 10 years. Records of 150 families were examined, ultrasound reports were obtained from 242 people at 50% prior risk, and 37 families were typed for DNA markers. The fraction of APKD resulting from loci unlinked to PKD1 (designated PKD2 here) was calculated at 2-94% (upper confidence limit 8-62%). Some subjects who were negative on initial scan later gave a positive scan, but there was no example of a definite gene carrier aged over 30 giving a negative scan. In families large enough for linkage analysis, most people who were at 50% prior risk could be given a final risk below 5% or above 95%, by using combined ultrasound and DNA studies.
(JMed Genet 1994;31:115-120) Adult polycystic kidney disease is one of the commonest serious autosomal dominant diseases, affecting between 1 in 1000 and 1 in 2500 white people. Renal function is impaired as fluid filled cysts increase in size and number, replacing tissue of the renal cortex with nonfunctional material and damaging the interstitial cortex. Of all patients requiring kidney transplants, 6% to 10% suffer end stage renal failure as a result of APKD." The gradual development of cysts gives the disease a marked age dependent penetrance, and the course is very variable. The risk of end stage renal failure has been estimated as 2% before the age of 40, 23% at the age of 50, and 48% at 73 years.'
Few people request prenatal diagnosis of APKD, but presymptomatic screening is important because complications of APKD threaten the health of gene carriers if untreated.45 Presymptomatic diagnosis has been possible for some time through renal imaging. Ultrasonographic scanning is the method of choice, being safe, inexpensive, and non-invasive. A crucial question for genetic counselling is the sensitivity of ultrasound scanning for detecting early manifestations of the disease. In an early study using first generation technology, Bear et a16 analysed data on 17 4 million. We have studied 150 families ascertained through the register. This cohort enables us to estimate the proportion of unlinked (PKD2) kindreds in the study population, to study the reliability of ultrasonographic scanning using modern imaging equipment, and to examine the concordance between USS data and genetic markers. Combining the data permits an overview of the effectiveness of molecular and ultrasonographic techniques combined in presymptomatic and prenatal diagnosis.
Materials and methods

ASCERTAINMENT AND SELECTION OF FAMILIES
All families were ascertained through an index patient referred from a renal unit in the north Marker types: RFLP, restriction fragment length polymorphism; VNTR, variable number of tandem repeats; (CA) , microsatellite. Marker order: 16pter-D16S85-(D16S84,D16S145)-
* P Harris, personal communication.
Register. Index cases and all subjects presenting with symptoms were excluded from the analysis of ultrasound error rates. Subjects were assigned an age class according to the date when they were first examined by ultrasonography. Scan reports were classified as positive, negative, or equivocal. Following Bear et al,6 the criterion for a positive report was at least one cyst in each kidney and one kidney having more than one cyst. Most of the ultrasonographic scans were performed by a single experienced consultant radiologist using either a Hitachi EUB 25M scanner with a 3 5 MHz linear array or an Acuson 128 scanner with a 3-5 MHz linear array or sector probe. For each age class the frequency of false negative USS diagnosis was estimated by comparing observed and expected rates of positive results. The expected frequency of positive results depends on age. It is always less than 50% because only asymptomatic people are considered. In a group of N people all at 50% prior risk, of whom A have already presented with symptoms, the proportion of gene carriers among asymptomatic people is {(IN)-A}/ (N-A). This was compared with the proportion of people examined whose scan was positive (equivocal scans were counted as negative for this purpose).
A 95% confidence interval was calculated for the observed rate of positive scans Table 6 shows the findings in 78 subjects with informative DNA and ultrasound results. There were five evident discrepancies. Two of these were from family 825 which is probably segregating the unlinked disease (see above). Two, from two different families, inherited a high risk haplotype but were negative on scan (table 6) . One further person (subject 33 in family 106) had a low risk haplotype and an equivocal scan.
Discussion STRUCTURE OF THE FAMILY SET
Of 150 families studied, 114 had two or more affected cases. The remaining 36 families each contained only one affected person. These were excluded because of the risk that there was a new mutation to APKD, or a disease distinct from APKD. Most of these cases are probably the result of APKD but appear sporadic because of a mild phenotype and the failure of the gene to manifest as a diagnosed complaint.
PROPORTION OF FAMILIES NOT LINKED TO PKD1
One out of 34 informative families (table 3) probably has the unlinked disease, giving a rate of 0-029 (upper 95% confidence limit 0 086). This latter figure (0 086) has been used as the prior probability in subsequent individual risk calculations. Our figure agrees with estimates from North America (0.04)12 and Scotland (0-03),26 but is lower than the European estimate of 0-14.'4 Parfrey et al'3 suggested that the unlinked disease shows a milder course than PKD 1. This would lead to an increased proportion of non-PKD 1 disease among "sporadic" cases and kindreds with low numbers of clearly affected subjects. These families are less suitable for linkage analysis. Thus it is possible that there is a selective bias against the inclusion of non-PKD 1 families in linkage based clinical studies.
FALSE NEGATIVE RATE OF ULTRASONOGRAPHY
Realistic genetic counselling of family members at risk of APKD requires knowledge of the risk that a gene carrier will give a negative ultrasonograph. This error rate comes partly from failure to see cysts which are there, and partly from late development of cysts. The rate of development might be different in PKD1 and PKD2. The most quoted error rates come from the work of Bear et al6 on 17 kindreds in Newfoundland. In the second and third decades these rates were calculated as 25% and 12% respectively. Scanning technology has improved since that study. The more recent study of Bear et al7 (based only on families with linkage results suggesting PKD 1) revised the error rates to 8% in the second decade and approaching zero in the third decade and thereafter.
Our data broadly agree with these updated findings of Bear et al. 7 Statistically we did not see false negative scans after the age of 10, although anecdotally there were cases. We calculated 95% confidence intervals as explained above for the observed positive rate.
Throughout the 10-39 age groups, the lower confidence limit of observed positives was equal to or greater than the expected frequency (table 4); thus this approach does not point to the presence of a significant false negative rate.
These statistics are based on small numbers and on certain assumptions. We necessarily calculated the expected rate from the whole of the age group, including people not scanned. We assumed that the proportion of gene carriers in the subset examined by USS was the same as among the whole age group. This assumption might be wrong: some people may have presented for screening because they had noticed symptoms, or conversely people with minor symptoms might have declined screening to avoid confirming their fears. In the absence of data, it is impossible to say whether either of these biases occurred. Anecdotally we have detected false negative tests in certain subjects over 10 years old, from the data on repeat scans (table 5) and from the comparison of genetic marker data with ultrasonography (table 6). Table 5 shows 10 asymptomatic subjects whose scan status changed on repeat examination. Seven out of these 10 subjects developed imageable renal cysts or an abnormal cortex appearance (equivocal finding) in the second or third decades. We discourage screening in asymptomatic children, hence the small number scanned in the 0-9 age group, who otherwise would no doubt have produced many cases of changed scan reports. Clearly a negative scan before the age of 30 does not exclude risk of APKD.
CONCORDANCE BETWEEN GENETIC MARKER AND ULTRASONOGRAPHIC DATA
The concordance between genetic marker and USS data in our series is strong (table 6) although there were a number of conflicts. Two members of family 825 show nonconcordance. One is clearly affected and one is unaffected. The disease in this family is probably not PKD 1 (table 3) . Three other cases of non-concordance have occurred. Subject 4 from family 138 is aged 26 and has inherited high risk close flanking markers despite having four negative USS between the ages of 18 and 24. Mlink'7 gives this subject a > 98% risk of carrying the APKD gene despite the conflicting information. Non-penetrance is the likely explanation of this false negative result. In family 814, subject 8 has had two negative scans at the age of 52, yet she has the same high risk haplotype as her affected sib. The disease in this family is almost certainly PKD1 (table  3) . However, their parents are dead, so an alternative to non-penetrance is that the affected parent was homozygous for these marker alleles. Person 33 from family 106 was originally diagnosed as affected but has the low risk haplotype. This large family, which has previously been described,'5 has unambiguous PKD1. Reassessment of the ultrasound data showed the cysts were observed in only one kidney (so this case did not meet the diagnostic criteria of Bear et al), and the subject has not reported any symptoms. The likely explanation is a false positive assignment of APKD. Reeders et aP7 have calculated that the false positive rate of ultrasonographic diagnosis may be as high as 2%. We thank Dr P Harris for markers pNL56 and SM7 and for typing SM6A. In addition we would like to acknowledge the contribution of the European Concerted Action "Towards prevention of renal failure caused by inherited polycystic kid- 
